rs114609505

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000065.5(C6):​c.542C>T​(p.Thr181Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00687 in 1,613,826 control chromosomes in the GnomAD database, including 57 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0051 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0071 ( 51 hom. )

Consequence

C6
NM_000065.5 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.494

Publications

11 publications found
Variant links:
Genes affected
C6 (HGNC:1339): (complement C6) This gene encodes a component of the complement cascade. The encoded protein is part of the membrane attack complex that can be incorporated into the cell membrane and cause cell lysis. Mutations in this gene are associated with complement component-6 deficiency. Transcript variants encoding the same protein have been described.[provided by RefSeq, Nov 2012]
C6 Gene-Disease associations (from GenCC):
  • complement component 6 deficiency
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009862632).
BP6
Variant 5-41195837-G-A is Benign according to our data. Variant chr5-41195837-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377318.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C6NM_000065.5 linkc.542C>T p.Thr181Ile missense_variant Exon 5 of 18 ENST00000337836.10 NP_000056.2 P13671

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C6ENST00000337836.10 linkc.542C>T p.Thr181Ile missense_variant Exon 5 of 18 1 NM_000065.5 ENSP00000338861.5 P13671

Frequencies

GnomAD3 genomes
AF:
0.00509
AC:
774
AN:
152144
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000990
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0167
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00764
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00599
AC:
1504
AN:
251278
AF XY:
0.00560
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0162
Gnomad NFE exome
AF:
0.00930
Gnomad OTH exome
AF:
0.00522
GnomAD4 exome
AF:
0.00706
AC:
10321
AN:
1461564
Hom.:
51
Cov.:
32
AF XY:
0.00673
AC XY:
4894
AN XY:
727106
show subpopulations
African (AFR)
AF:
0.00105
AC:
35
AN:
33468
American (AMR)
AF:
0.00125
AC:
56
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00119
AC:
31
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.0164
AC:
876
AN:
53374
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00810
AC:
9010
AN:
1111790
Other (OTH)
AF:
0.00518
AC:
313
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
518
1037
1555
2074
2592
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00508
AC:
774
AN:
152262
Hom.:
6
Cov.:
32
AF XY:
0.00513
AC XY:
382
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.000987
AC:
41
AN:
41552
American (AMR)
AF:
0.00164
AC:
25
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.0167
AC:
177
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00765
AC:
520
AN:
68016
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
41
82
124
165
206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00653
Hom.:
15
Bravo
AF:
0.00396
TwinsUK
AF:
0.00971
AC:
36
ALSPAC
AF:
0.00701
AC:
27
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00802
AC:
69
ExAC
AF:
0.00673
AC:
817
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00556
EpiControl
AF:
0.00634

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 02, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

C6: BP4, BS2 -

C6-related disorder Benign:1
May 18, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Complement component 6 deficiency Benign:1
Oct 21, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
4.3
DANN
Benign
0.95
DEOGEN2
Benign
0.14
T;T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.77
FATHMM_MKL
Benign
0.079
N
LIST_S2
Benign
0.22
.;T
MetaRNN
Benign
0.0099
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N;N
PhyloP100
0.49
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.7
N;N
REVEL
Benign
0.067
Sift
Benign
0.17
T;T
Sift4G
Benign
0.13
T;T
Polyphen
0.0020
B;B
Vest4
0.25
MVP
0.53
MPC
0.038
ClinPred
0.0043
T
GERP RS
2.6
Varity_R
0.054
gMVP
0.53
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114609505; hg19: chr5-41195939; COSMIC: COSV54707251; COSMIC: COSV54707251; API